Search

Alpha 4 Integrin Antagonists

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 1 Year: 2002 Page: 1229-1253
Author(s): David Y. Jackson

Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects

Journal: Current Immunology Reviews (Discontinued)
Volume: 8 Issue: 2 Year: 2012 Page: 118-134
Author(s): Dulce Soler-Ferran,Michael J. Briskin

Synthesis and Biological Evaluation of 1,2,4-Triazolo[2,3-a]pyrrole Derivatives as Alpha-4 ( α4) Integrin Antagonists

Journal: Letters in Drug Design & Discovery
Volume: 2 Issue: 8 Year: 2005 Page: 601-605
Author(s): Edward C. Lawson, William A. Kinney, Rosemary J. Santulli, Carol M. Fisher, Bruce P. Damiano, Bruce E. Maryanoff

Crohns Targeted Therapy: Myth or Real Goal?

Journal: Current Drug Discovery Technologies
Volume: 6 Issue: 4 Year: 2009 Page: 290-298
Author(s): Klaus J. Schmidt, Jurgen Buning, Carsten Jankowiak, Hendrik Lehnert, Klaus Fellermann

An Effective Vaccination Approach Augments Anti-HIV Systemic and Vaginal Immunity in Mice with Decreased HIV-1 Susceptible α4β7high CD4+ T Cells

Journal: Current HIV Research
Volume: 11 Issue: 1 Year: 2013 Page: 56-66
Author(s): Wei Zhu,Guoping Shi,Haijun Tang,Dorothy E. Lewis,Xiao-Tong Song

Journal: Current Protein & Peptide Science
Volume: 9 Issue: 3 Year: 2008 Page: 221-226
Author(s): R. Stoll, A. Bosserhoff

Radiochemical Evaluation and In Vitro Assessment of the Targeting Ability of a Novel ^99mTc-HYNIC-RGD for U87MG Human Brain Cancer Cells

Journal: Current Radiopharmaceuticals
Volume: 10 Issue: 2 Year: 2017 Page: 139-144
Author(s): Hanieh Karimi,Nourollah Sadeghzadeh,Saeid Abediankenari,Farzaneh Rezazadeh,Fereshteh Hallajian

Therapeutic Impact of Sphingosine 1-phosphate Receptor Signaling in Multiple Sclerosis

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16 Issue: 7 Year: 2016 Page: 547-554
Author(s): Kristina Candido,Henry Soufi,Mausumi Bandyopadhyay,Subhajit Dasgupta

Evaluation of Local Injection of Bevacizumab against Triple-Negative Breast Cancer Xenograft Tumors

Journal: Current Pharmaceutical Design
Volume: 25 Issue: 8 Year: 2019 Page: 862-870
Author(s): Xin Jiang,Qiao-Li Zhang,Tie-Gang Liu,Wei-Peng Zhao,Ming Yang,Li-Na Wang,Wei-Liang Sun,Lin Pan,Ai-Ping Luo,Jin-Chang Huang,Xiao-Hong Gu

The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non-Responders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17 Issue: 6 Year: 2018 Page: 464-472
Author(s): Rodica Balasa,Ciurba Bianca,Voidezan Septimiu,Simu Iunius,Hutanu Adina,Andone Sebastian,Romaniuc Andreea,Motataianu Anca,Maier Smaranda